It's a complex process, but a challenge taken on by AstraZeneca, which is expanding its Rockville facility, specifically to work on cell therapy in specially designed labs.

AstraZeneca has shown its commitment to China amid investigations into its executives and activities, outlining plans to establish a global strategic R&D center in Beijing as part of a $2.5 ...

AstraZeneca has refuted allegations its staff “refuse to cooperate and respect” the U.K. marketing code. | AstraZeneca has refuted allegations its staff “refuse to cooperate and respect ...

Find out why AstraZeneca FluMist is one of the best inventions of 2024. ... (Caregivers can administer the spray for children.) AstraZeneca expects to have doses ready for the fall-2025 flu season.

AstraZeneca plans to make the vaccine available through a third-party online pharmacy. ... US FDA approves AstraZeneca's self-administered nasal spray flu vaccine. Reuters . Fri, Sep 20, 2024, ...

AstraZeneca plans to make the vaccine available through a third-party online pharmacy. US FDA approves AstraZeneca's self-administered nasal spray flu vaccine Skip to main content ...

AstraZeneca has appointed WPP as one of its primary oncology network partners. Under WPP’s new remit as a global creative partner, the agency will support U.S. and global advertising for AstraZeneca’s ...

Drawn up syringes containing the AstraZeneca COVID-19 vaccines and the empty vial are seen in a tray at the Claremont Showgrounds Covid-19 Vaccination Clinic on May 03, 2021 in Perth, Australia.

AstraZeneca’s COVID-19 vaccine Vaxzevria is no longer being manufactured or supplied due to declining demand, the company said Wednesday.. It is also withdrawing the vaccine’s authorization to ...

AstraZeneca has started to pull its Covid-19 vaccine from global markets because of low demand, the pharmaceutical giant said. The decision closes the chapter on a shot that was widely used in the ...

AstraZeneca ADRs were up 5.6% to $75.20 as of noon ET and have gained nearly 12% so far this year. They reached their all-time high of $76.56 precisely one year ago. Article Sources ...

AstraZeneca is adding to the explosion of interest in radiopharmaceuticals, inking a $2 billion buyout to meld Fusion Pharmaceuticals with its cancer unit. Fusion’s pipeline is led by a PSMA ...